(Press-News.org) MINNEAPOLIS — Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased risk of death, brain surgery or longer hospital stays, according to a study published on January 28, 2026, in Neurology®, the medical journal of the American Academy of Neurology.
For the study, researchers looked at serotonergic antidepressants, which treat anxiety and depression by increasing serotonin activity in the brain. These included selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs).
“Concerns have previously been raised that serotonergic antidepressants might increase the risk of bleeding in the brain or complicate early recovery after traumatic brain injury,” said study author Jussi P. Posti, MD, PhD, of the University of Turku in Finland. “However, our study found no evidence to support those concerns.”
The study included 54,876 people in Finland who were 16 or older when hospitalized with a TBI. A total of 14% used serotonergic antidepressants at the time of the TBI.
Researchers reviewed national prescription records for preinjury antidepressant use and medical records to determine how many people died within a month, whether they needed emergency brain surgery, and how long they stayed in the hospital.
A total of 4,105 people died within a month. This included 7.6% of those taking antidepressants and 7.5% of people who did not.
After adjusting for factors such as age, sex and other health conditions, researchers found people taking antidepressants before injury were no more likely to die within a month than those not taking them.
Antidepressant users were slightly less likely to require emergency brain surgery to relieve pressure or bleeding in the brain and prevent further damage.
Of the total participants, 6.8% of the antidepressant users and 8.6% of those who did not use antidepressants needed emergency brain surgery. After adjustments, antidepressant users had an 11% lower risk.
The amount of time in the hospital was the same for both groups.
“These findings provide reassurance for people who take antidepressants that antidepressant use does not appear to worsen early recovery after traumatic brain injury,” said Posti. “Future studies should examine whether these results hold true for long-term recovery and across different health care settings.”
A limitation of the study was that it was conducted only at hospitals and health care centers in Finland, so results may vary in other areas.
The study was supported by the Finnish government, the Paulo Foundation, Paavo Nurmi Foundation, Research Council of Finland, Sigrid Jusélius Foundation and Finnish Foundation for Cardiovascular Research.
Discover more about traumatic brain injury at Brain & Life®, from the American Academy of Neurology. This resource offers a website, podcast, and books that connect patients, caregivers and anyone interested in brain health with the most trusted information, straight from the world’s leading experts in brain health. Follow Brain & Life® on Facebook, X, and Instagram.
The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.
Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, Instagram, LinkedIn, and YouTube.
END
Antidepressants not associated with serious complications from TBI
2026-01-28
ELSE PRESS RELEASES FROM THIS DATE:
Evasive butterfly mimicry reveals a supercharged biodiversity feedback loop
2026-01-28
Key points
Scientists constructed a family tree for butterflies in the genus Adelpha, which are native to North and South America and display perplexing color patterns that may represent an unusual case of evasive mimicry.
They found the first known correlation between latitude and the rate of mimicry evolution in butterflies, consistent with a longstanding theory of biodiversity that can trace its origin to Alfred Russel Wallace, the co-discoverer of evolution by natural selection.
The tree helps ...
Hearing angry or happy human voices is linked to changes in dogs’ balance
2026-01-28
In a small study, dogs experienced both stabilization and destabilization of their balance upon hearing angry or happy human voices, but angry voices were linked to the biggest destabilizing effects. Nadja Affenzeller and colleagues at the University of Veterinary Medicine, Vienna, Austria, present these findings in the open-access journal PLOS One on January 28, 2026.
For humans and animals alike, stable posture underpins the ability to stand still, walk, and perform other activities without falling. To maintain stability, our muscles rely on visual cues as well as the body’s sense of its own position. Recent research in humans suggests that external sounds may also ...
Microplastics are found in a third of surveyed fish off the coasts of remote Pacific Islands
2026-01-28
A third of fish living in the remote coastal waters of the Pacific Island Countries and Territories are contaminated with microplastics, with especially high rates in Fiji, according to an analysis publishing January 28, 2026 in the open-access journal PLOS One by Jasha Dehm at the University of the South Pacific and colleagues.
Microplastic pollution in marine environments is a global issue impacting ecosystems and human health. Despite their remoteness, the Pacific Island Countries and Territories (PICTs) may be particularly vulnerable to microplastic pollution because of rapid urbanization ...
De-stigmatizing self-reported data in health care research
2026-01-28
Professor Nisreen Alwan calls to de-stigmatize self-reported data in health care research, highlighting Long COVID as one setting where it has unique strengths over 'objective' data.
Article URL: https://plos.io/4qBRszB
Article Title: The Stigma of self-report in health research: Time to reconsider what counts as “Objective”
Author Countries: United Kingdom
Funding: The author(s) received no specific funding for this work. END ...
US individuals traveling from strongly blue or red US counties may favor everyday travel to like-minded destinations
2026-01-28
A new analysis of 471 U.S. counties has found that, for everyday travel, people from counties with particularly strong political leanings—whether liberal or conservative—are more likely to visit like-minded destinations. Zhengyi Liang and Jaeho Cho of the University of California, Davis, U.S., present these findings in the open-access journal PLOS One on January 28, 2026.
Prior research has shown that U.S. residents increasingly live in areas where their neighbors share similar political leanings. This clustering can limit how often people of differing political views cross paths with each other, further deepening political polarization.
In ...
Study reveals how superionic state enables long-term water storage in Earth's interior
2026-01-28
The cycling of water within Earth's interior regulates plate tectonics, volcanism, ocean volume, and climate stability, making it central to the planet's long-term evolution and habitability and a key scientific question.
While subducting slabs are known to transport water into the mantle, scientists have long assumed that most hydrous minerals dehydrate at high temperatures, releasing fluids as they descend. Whether water can survive the extreme conditions of the deep lower mantle, however, has remained an open question.
To fill this knowledge gap, a research team from the Institute of Geochemistry of the Chinese Academy of Sciences ...
AI machine learning can optimize patient risk assessments
2026-01-28
Cardiovascular disease continues to be the leading cause of death worldwide. To save lives, constantly improving diagnostic and risk assessments is vital. One researcher from the University of Missouri School of Medicine is exploring ways to do just that by using machine learning, which is a type of artificial intelligence (AI).
Some assessments use traditional statistical analysis to predict a patient’s risk. These predictive models have already been implemented across ...
Efficacy of immunosuppressive regimens for survival of stem cell-derived grafts
2026-01-28
While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise immunosuppressive regimen needed remains elusive. Now, researchers have identified optimized immunosuppressive strategies that allow transplanted iPSC-CMs to survive without immune rejection in non-human primates. These findings advance the clinical potential of regenerative therapies for severe heart failure, addressing a major challenge in translating stem cell science into effective human treatments.
Heart failure remains one of the most pressing global health challenges, ...
Glowing bacterial sensors detect gut illness in mice before symptoms emerge
2026-01-28
UBC researchers have engineered gut bacteria that dim their fluorescent glow in the presence of illness.
Their findings, published in Cell today, could improve how we diagnose problems in the gut by using bacteria that already live there.
“Our biosensors could improve the ability to predict how diseases in the gut progress, identifying early changes that could aid preventative interventions,” said co-first author Juan Camilo Burckhardt (he/him), a doctoral candidate in the department ...
GLP-1 RAs and prior major adverse limb events in patients with diabetes
2026-01-28
About The Study: In this nationwide cohort study of patients with diabetes and prior major adverse limb events, treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) was associated with significantly lower risks of recurrent limb events, cardiovascular events, all-cause mortality, and kidney disease progression compared with dipeptidyl peptidase-4 inhibitors. These findings support the preferential use of GLP-1 RAs for secondary prevention in this high-risk population.
Corresponding Author: To contact the corresponding ...